Klin Farmakol Farm. 2005;19(3):146-148

Primary compliance with lipid lowering therapy

Jan Strojil, Karel Urbánek, Mgr. Lucie Sobolová
Ústav farmakologie LF UP a FN Olomouc

Compliance with medication therapy is a well-recognised and important issue. This paper gives a short overview of published work on compliance in lipid-lowering therapy, with special focus on primary non-compliance in statin therapy. We analysed prescription database in the Teaching Hospital in Olomouc and identified all prescriptions issued for lipid-lowering agents in 2003. These data were compared to the database of claimed prescriptions obtained from the insurance company. There were 12,182 packages prescribed to 2,715 patients. 8.1% of prescribed drugs remained unclaimed by 17.2% of the patients. Differences between patient groups (age, sex) were not statistically significant. Non-compliance with medication is one of the first things that need to be considered when a patient fails to respond to treatment. As it seems, primary non-compliance plays an important role. In further research, we would like to include more data about the patients’ treatment in the analysis and try to correlate this with their compliance.

Keywords: Key words: compliance, primary non-compliance, statins, adherence.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Strojil J, Urbánek K, Sobolová L. Primary compliance with lipid lowering therapy. Klin Farmakol Farm. 2005;19(3):146-148.
Download citation

References

  1. Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager. 2005 Apr; 16 (2): 47-51. Go to original source... Go to PubMed...
  2. Dunbar-Jacob J, Burke LE, Pyczynski S. Clinical assessment and management of adherence to medical regimens. In: Nicassio PM, Smith TW, eds. Managing Chronic Illness: A Biopsychosocial Perspective. Washington, DC: American Psychological Association; 1995. Go to original source...
  3. Dubanoski JP. Preventive health behavior: a model of adherence prediction. Dissertation Abstracts International. 1988; 48 (10-B): 3152.
  4. Dunbar J. Predictors of patient adherence: patient characteristics. In: Shumaker SA, Schron EB, Ockene JK, eds. The Handbook of Health Behavior Change. New York, NY: Springer Publishing Co Inc; 1990.
  5. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm. 1991; 48: 1978-1988. Go to original source...
  6. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva (Switzerland): World Health Organization; 2003.
  7. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003; 25: 2958-2971. Go to original source... Go to PubMed...
  8. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004; 4: 191-195. Go to original source... Go to PubMed...
  9. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther 2001; 26: 331-332. Go to original source... Go to PubMed...
  10. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet. 2004; 364 (9436): 771-777.
  11. Wei L, Wang J, Thompson P Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a 6 year follow up study. Heart 2002; 88: 229-233. Go to original source... Go to PubMed...
  12. Kopjar B, Sales AE, Pineros SL, Sun H, Li YF, Hedeen AN. Adherence with statin therapy in secondary prevention of coronary heart disease in Veterans Administration male population. Am J Cardiol 2003; 92: 1106-1108. Go to original source... Go to PubMed...
  13. Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005; 28 (3): 595-599. Go to original source... Go to PubMed...
  14. Schultz JS, O'Donnell JC, McDonough KL, Sasane R, Meyer J. Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care. 2005; 11 (5): 306-312.
  15. Willich SN, Muller-Nordhorn J, Sonntag F, Voller H, Meyer-Sabellek W, Wegscheider K, Windler E, Katus H. Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study. Am Heart J. 2004; 148 (6): 1060-1067. Go to original source... Go to PubMed...
  16. Barat I, Andreasen F, Damsgaard EMS. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 2001;51:615-22. Go to original source... Go to PubMed...
  17. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BJM. 1993 Oct 2; 307 (6908): 846-848. Go to original source... Go to PubMed...
  18. T W Loong. Primary Non-Compliance in a Singapore Polyclinic. Singapore Med J 1999; Vol 40 (11).
  19. Ekedahl A, Mansson N. Unclaimed prescriptions after automated prescription transmittals to pharmacies. Pharm World Sci. 2004 Feb; 26 (1): 26-31. Go to original source... Go to PubMed...
  20. Jones I, Britten N. Why do some patients not cash their prescriptions? Br J Gen Pract. 1998 Jan; 48 (426): 903-905.
  21. Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005 Mar; 28 (3): 595-599. Go to original source... Go to PubMed...
  22. Huser MA, Evans TS, Berger V. Medication adherence trends with statins. Adv Ther. 2005; 22 (2): 163-171. Go to original source... Go to PubMed...
  23. Gebhardt MW, Governali JF, Hart EJ. Drug related behavior, knowledge and misconceptions among a selected group of senior citizens. J Drug Educ. 1978; 8: 85-92. Go to original source...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.